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Edited by Gerrit van MeerAbstract Rat cytosolic sialidase is expressed at elevated levels
in skeletal muscle and is believed to play a role in the myogenic
diﬀerentiation of muscle cells. Here, we observed varying levels
of enhancement of sialidase activity in the presence a range of
divalent cations. In particular, a signiﬁcant enhancement of
activity was observed in the presence of Ca2+. Conversely, inhi-
bition of the sialidase activity was found when the enzyme was
incubated in the presence of Cu2+, EDTA, and a range of carbo-
hydrate-based inhibitors. Finally, an investigation of the enzy-
matic hydrolysis of a synthetic substrate, 4-methylumbelliferyl
N-acetyl-a-D-neuraminide, by 1H NMR spectroscopy revealed
that the reaction catalysed by rat skeletal muscle cytosolic sial-
idase proceeds with overall retention of anomeric conﬁguration.
This result further supports the notion that all sialidases appear
to be retaining enzymes.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cytosol1. Introduction
In addition to being implicated in lysosomal catabolism,
mammalian sialidases are also thought to be responsible for
the modulation of functional biomolecules involved in many
biological processes [1]. Miyagi et al. [1–3] have identiﬁed four
types of mammalian sialidases that diﬀer not only in their sub-
cellular location, but also their catalytic and immunological
properties. These sialidases are found within the lysosomes,
the lysosomal membrane, the cytosol, and the plasma mem-
brane. The distinct locations and diﬀering catalytic properties
of these sialidases suggest that each may perform a unique
role. In general, however, little is understood regarding the
function of these enzymes in part due to their apparent insta-
bility and low activity, which makes their puriﬁcation and
characterisation extremely challenging.
Miyagi et al. [4,5] have successfully cloned, expressed and
puriﬁed to homogeneity the cytosolic sialidase from rat skele-
tal muscle. Moreover, it was shown that the cytosolic sialidase
had a higher activity and expression in the skeletal muscle*Corresponding author. Fax: +61 7 5552 9040.
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doi:10.1016/j.febslet.2004.12.077cytosol, compared to other subcellular sialidases in other tis-
sues. The cytosolic sialidase has been shown to have activity
towards a2,3-sialylglycoconjugates, including sialyloligosac-
charides, sialylglycopeptides and gangliosides [5–7]. In the con-
text of cytosolic resident asparagine-linked glycopeptides it is
of value to note that a cytosolic peptide:N-glycanase (PNGase,
EC 3.5.1.52) has been identiﬁed and characterised [8–11]. This
enzyme appears to play a key role in deglycosylation of mis-
folded glycoproteins that have been exported out of the ER
to the cytosol [8–11]. The fact that free N-linked glycans and
PNGase-released glycans are resident in the cytosol may also
provide a rich source of substrates for the cytosolic sialidase
and may suggest that the enzyme plays a role in the turnover
of such glycans.
The explicit reasons for the high expression and the physio-
logical function of the cytosolic sialidase in skeletal muscle are
still not entirely clear. Miyagi and coworker [12] and more re-
cently Fanzani et al. [13] have suggested that this enzyme may
play an important role in myoblast diﬀerentiation by desialyla-
tion of glycoconjugates involved in the process.
Evidence has emerged to implicate cytosolic sialidase in
muscle metabolism [14–23]. These ﬁndings suggest that the
agrin-signalling pathway can be activated by sialidase or cal-
cium treatment. Of particular interest is the observation that
applied N-acetylneuraminic acid not only decreases acetyl
choline receptor (AchR) clustering but also diminishes the
tyrosine phosphorylation of muscle-speciﬁc kinase (MuSK)
and the b-subunit of AChR [23]. It therefore appears that
N-acetylneuraminic acid may play a regulatory role in the
signal transduction events of neuromuscular synapse
formation.
Clearly, further characterisation of this enzyme will help to
elucidate the biological function and putative role of this sial-
idase in muscle diﬀerentiation. Herein, we report the use of a
N-acetylneuraminic acid-based aﬃnity chromatography ma-
trix to generate partially puriﬁed cytosolic skeletal muscle sial-
idase with high sialidase activity. Furthermore, as a result of
the apparent poor stability of the enzymatic activity that had
previously been a signiﬁcant problem plaguing studies of this
enzyme [1–3], we thought it of value to undertake a stabilisa-
tion study of the sialidase activity using additives such as cal-
cium. We have also investigated the susceptibility of the
enzyme to inhibition by a number of N-acetylneuraminic
acid-based compounds and sialylmimetics (Fig. 1). All of the
carbohydrates evaluated are either known inhibitors of other
sialidases or are potential sialidase inhibitors. Finally, weblished by Elsevier B.V. All rights reserved.
Table 1
The eﬀect of additives on the activity of partially puriﬁed recombinant
rat cytosolic sialidase
Additivea Concentration (mM) Residual activity (%)
CaCl2 7 1018
CuCl2 7 50
LiCl 7 142
MnCl2 7 784
MgCl2 7 382
Fig. 1. Carbohydrates used as potential inhibitors of rat cytosolic
sialidase 1 Neu5Ac-2-S-(a2,3)-Galb1Me; 2 Neu5Ac-S-(a2,6)-
Glcb1Me; 3 Neu5Ac-2-S-(a2,6)-Galb1Me; 4 Neu5Ac2en; 5 iso-propyl
2-acetamido-2-deoxy- D4-b-D-glucopyranosiduronic acid; 6 methyl
6-thio-6-(20-phenylacetic acid)-b-D-glucopyranoside; 7 methyl 6-thio-
6-(2 0-propionic acid)-b-D-galactopyranoside; 8 methyl 6-thio-6-(20-
phenylacetic acid)-b-D-galactopyranoside.
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of sialidases from various sources by 1H NMR spectroscopy.
In light of these previous studies, we have taken the opportu-
nity to further characterise the sialidase activity from cytosolic
skeletal muscle by using 1H NMR spectroscopy to monitor the
hydrolysis of a synthetic sialoside.KCl 7 109
EDTA 1 48
BSA 0.3% 158
(1) 0.2 82
(2) 0.2 102
(3) 0.2 103
(4) 0.2 4
(5) 0.2 38
(6) 0.2 98
(7) 0.2 95
(8) 0.2 96
Percentage activities are in comparison to enzyme without additive.
aCompound numbers refer to Fig. 1.2. Materials and methods
2.1. Expression and puriﬁcation of cytosolic sialidase
The cDNA clone (pGEX-2T-SD) of rat muscle cytosolic sialidase
was kindly provided by Dr. Taeko Miyagi (Miyagi Prefectural Cancer
Centre, 47-1 Nodayama, Japan) and was expressed as previously
described [4]. An aﬃnity matrix derived from the neuraminic acid ana-
logue 2-S-(aminoethyl) 5-acetamido-2-thio-D-glycero-a-D-galacto-2-
nonulopyranosidonic acid was prepared using a previously described
method [31,32]. The sialidase puriﬁcation by aﬃnity chromatography
was performed at 4 C according to published methods [31,32].2.2. Sialidase activity assay
Sialidase activity was measured by the modiﬁed ﬂuorometric method
[33] using the ﬂuorescent substrate 4-methylumbelliferyl N-acetyl-a-D-
neuraminide (MUN). The hydrolysis reaction was performed in
20 mM NaOAc buﬀer (pH 6.1) containing 4 mM CaCl2. One unit of
sialidase activity is deﬁned, as the amount of enzyme needed to cata-
lyse the hydrolysis of 1 lmol of MUN/hour under the conditions of
the ﬂuorometric assay.
2.3. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE) and immunoblot analysis
SDS separating gels (12%) were run according to the published
method of Laemmli [34] using silver staining for protein visualisation.
For immunoblot analysis protein samples fractionated by SDS–PAGE
were transferred to a PVDF membrane and were subjected to immuno-
detection. The primary antibody was polyclonal rabbit anti-rat skeletal
muscle sialidase antibody [2] (kindly provided by T. Miyagi). The sec-
ondary antibody used was sheep polyclonal anti-rabbit IgG conjugated
with horseradish peroxidase (Silenus). Bands were visualised using an
enhanced chemiluminescence reagent (Boehringer–Mannheim),
according to the manufacturers instructions.
2.4. Kinetic studies
The inﬂuence of various additives such as metal ions, BSA and
EDTA on sialidase activity of expressed and partially puriﬁed enzyme
samples was investigated. Additionally, a number of carbohydrate-
based compounds (Fig. 1) synthesised in our laboratory [27,35–38]
were tested as potential inhibitors of the sialidase activity. Thus, the
additives were incubated at various concentrations (see Table 1) with
the sialidase and the activity measured using the modiﬁed ﬂuorometric
assay [33] described above.
For the inhibition studies of the carbohydrate-based compounds the
assay solution contained 0.2 mM MUN, 0.2 mM inhibitor, and
8 · 103 units of partially puriﬁed enzyme in 20 mM NaOAc buﬀer
(pH 6.1) containing 4 mM CaCl2.
2.5. MUN hydrolysis reaction
1H NMR spectroscopy was used to follow the hydrolysis of MUN
catalysed by sialidase. MUN (0.55 mg, 1.18 lmol) was incubated with
24 U of partially puriﬁed recombinant rat cytosolic sialidase in 600 lL
of NaOAc-d4/DCl (pH 6.1, uncorrected) containing 4 mM CaCl2 for
102 min. 1H NMR spectra (600 MHz, 298 K) were acquired periodi-
cally during this time period to monitor the progress of the hydrolysis
reaction. A control spectrum (time = 0) of a sample containing MUN
(1.18 lmol) in 600 lL of NaOAc-d4/DCl (pH 6.1, uncorrected) was
also acquired.
Fig. 3. 1H NMR (600 MHz, 298 K) spectra of the progress of the rat
cytosolic sialidase reaction. Spectra were obtained at the time points
indicated. The reaction was performed using 1.18 lmol of MUN and
24 U of partially puriﬁed recombinant rat cytosolic sialidase in 600 mL
of NaOAc-d4/DCl, pH 6.1 (uncorrected) with the addition of 4 mM
CaCl2. Resonances 1 and 4 are the H3eq and H3ax signals, respectively,
of a-Neu5Ac and 2 and 3 are the H3eq and H3ax signals, respectively,
of b-Neu5Ac.
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3.1. Aﬃnity chromatography
Partial puriﬁcation, as determined by SDS–PAGE, of the re-
combinant rat cytosolic sialidase was achieved by using 10 mL
of the aﬃnity matrix based on the N-acetylneuraminic acid
analogue 2-S-(aminoethyl) 5-acetamido-2-thio-D-glycero-a-D-
galacto-2-nonulopyranosidonic acid [26,27]. An immunoblot
analysis (Fig. 2) of the partially puriﬁed recombinant rat skel-
etal muscle cytosolic sialidase showed only two immunoreac-
tive bands with approximate molecular weights of 43 and
76 kDa in fractions containing sialidase activity. A molecular
weight of 43 kDa is consistent with the size of the cytosolic
sialidase isolated from rat skeletal muscle by Miyagi et al.
[2]. The 76 kDa band has been previously ascribed to a con-
taminant arising from the original protein used to raise anti-
bodies [2]. As can be seen from the immunoblot analysis
(Fig. 2) a sialidase active band at 43 kDa was obtained after
a ﬁnal elution with 0.5 M NaCl (lane 6) (see Fig. 2).
3.2. Kinetic studies of rat cytosolic sialidase
Table 1 summarises the eﬀect of additives on the activity of
the partially puriﬁed recombinant rat cytosolic sialidase. It is
evident from Table 1 that CuCl2 and EDTA markedly reduced
the sialidase activity while KCl had little eﬀect on the activity.
Increases in sialidase activity were noted on addition of 7 mM
CaCl2, MnCl2, MgCl2, LiCl or 0.3% BSA. An explanation for
the observed increase in sialidase activity as a result of BSA
addition is not clear and could be either non-speciﬁc eﬀects
of higher carrier protein concentration or some speciﬁc BSA
eﬀect. Strikingly, addition of CaCl2 lead to over a 1000% in-
crease in sialidase activity for partially puriﬁed enzyme and
555% for the crude enzyme extracts. Km values for the binding
of Ca2+ were calculated using the direct linear plot method [39]
and were found to be 0.2 mM for the enzyme and 1.1 mM for
the crude enzyme extracts. The response to calcium addition
displayed saturation kinetics.
A naturally occurring known lM inhibitor of a number of
sialidases [36] Neu5Ac2en (4, Fig. 1), inhibited rat cytosolicFig. 2. Immunoblot analysis of partially puriﬁed recombinant rat
cytosolic sialidase. Lane 1, culture medium; lane 2, wash step; lane 3,
ﬁnal wash fraction; lane 4, elution with 0.1 M NaCl; lane 5, elution
with 0.5 M NaCl (fraction 1); lane 6, elution with 0.5 M NaCl (ﬁnal
fraction).sialidase activity by over 95% at a concentration of 0.2 mM.
These results are in good agreement with those of Miyagi
et al. [3]. Interestingly, at the same concentration, iso-propyl
2-acetamido-2-deoxy-D4-b-D-glucopyranosiduronic acid (5), a
Neu5Ac2en mimetic in which the glycerol sidechain of
Neu5Ac2en is replaced by an aliphatic ether [37], resulted in
ca. 60% inhibition of the sialidase activity. None of the other
carbohydrate compounds listed in Table 1 or shown in Fig.
1 produced signiﬁcant inhibition of the recombinant sialidase
activity.
3.3. Rat cytosolic sialidase-catalysed hydrolysis of MUN
The recombinant rat cytosolic skeletal muscle sialidase-
catalysed hydrolysis of MUN, an N-acetylneuraminic acid-
based synthetic substrate, was monitored using 1H NMR
spectroscopy at 25 C as a time course reaction (Fig. 3). To
the deuterated NaOAc buﬀer (pH 6.1, uncorrected) incubation
medium containing MUN and 24 U of expressed partially
puriﬁed rat cytosolic skeletal muscle sialidase was added
4 mM CaCl2. The hydrolysis of MUN catalysed by the siali-
dase was monitored by acquiring spectra periodically and
examining the signals of the H3eq and H3ax protons of the sia-
lic acid portion of MUN that resonate at 2.9 and 1.65 ppm,
respectively, in the 1H NMR spectrum (Fig. 3). As the hydro-
lysis reaction proceeds, the intensities of the resonances at 2.9
and 1.65 ppm decrease with a concomitant increase in the
intensities of signals at 2.75 and 1.65 ppm corresponding to
the H3eq and H3ax protons of free a-Neu5Ac. The appearance
S. Albouz-Abo et al. / FEBS Letters 579 (2005) 1034–1038 1037of these resonances, due to a-Neu5Ac as the ﬁrst product of
release in the hydrolysis reaction (T = 2 min), indicate that
rat skeletal muscle cytosolic sialidase is a retaining sialidase,
i.e., the sialic acid portion of MUN binds in the active site
of rat cytosolic sialidase in the a-form and is released after
hydrolysis of the aglycon unit as a-Neu5Ac. The appearance
of other signals in the spectrum at 2.24 and 1.83 ppm, with
the concomitant decrease in the intensities of peaks due to a-
Neu5Ac is due to the mutarotation of a-Neu5Ac to the ther-
modynamically preferred b-Neu5Ac in solution. From the
spectra it is possible to determine that the hydrolysis reaction
is complete at T = 17 min and that equilibrium between the a-
and b-anomers of Neu5Ac has been reached within ca.
102 min.4. Discussion
The emergence of evidence that suggests the involvement of
cytosolic sialidase in myoblast diﬀerentiation [12,13], together
with the observed inﬂuence of sialidase, sialic acids and cal-
cium, in the tyrosine phosphorylation of muscle-speciﬁc kinase
(MuSK) and the aggregation of acetylcholine receptors [23] is
an exciting development in this ﬁeld. Clearly, any data that can
consolidate, or further develop an understanding of this body
of information is highly desirable.
The inﬂuence of metal ions on enzyme activity is of great
importance and may have implications on the enzymes func-
tion. In the present study, the eﬀect of calcium on recombinant
rat skeletal muscle cytosolic sialidase activity was found to be
dramatic with a 1000% increase in the observed sialidase activ-
ity. These results clearly demonstrate an increased inﬂuence of
added calcium on the partially puriﬁed enzyme compared to
the crude extracts. This may suggest that there are other com-
ponents in the crude extracts such as chelating agents or
endogenous inhibitors that either modulate the eﬀect of the
added calcium or inhibit the enzyme. Presumably, these com-
ponents are removed during the puriﬁcation procedure. It is
interesting to note that the further addition of calcium into sol-
uble partially puriﬁed enzyme not only restores enzyme activ-
ity, it also appears to increase activity. A possible explanation
for these observations is that calcium plays a crucial role in
either structural maintenance of the enzymes architecture or
in catalysis itself. This is not unlike the important role of cal-
cium in stabilisation of the binding region of Vibrio cholerae
sialidase [40].
Our investigation of other divalent metal ions led us to
conclude that the sialidase is also stimulated by the presence
of divalent magnesium and manganese ions. It is interesting
to note that puriﬁed rat liver cytosolic sialidase activity is
apparently inhibited by the divalent ions of Ca2+, Mn2+
and Mg2+ [5]. Cu2+ was found to have an inhibitory eﬀect
(50% inhibition at 7 mM) on the sialidase activity. This is
in good agreement with a similar observation by Miyagi
et al. [3].
The recombinant sialidase activity was inhibited by
Neu5Ac2en 4 (95%), a known sialidase inhibitor, and by
the previously reported [37] mimetic of Neu5Ac2en, iso-
propyl 2-acetamido-2-deoxy-D4-b-D-glucopyranosiduronic
acid 5 (62%). These compounds are designed to structurally
resemble the putative transition state, a sialosyl cation, of the
sialidase-catalysed reaction. We have previously found that 5inhibits other microbial sialidases such as inﬂuenza virus sial-
idase [37]. It is clear from this data that the cytosolic siali-
dase can accommodate hydrophobic groups in the C-6
glycerol binding domain. We have observed a similar hydro-
phobic group accommodation in microbial sialidases such as
V. cholerae sialidase [37,41,42] and inﬂuenza virus sialidase
[37]. Modest inhibition (18%) was also observed with the
a2,3-linked substrate-like compound Neu5Ac-2-S-(a2,3)-
Galb1Me 1, a thiosialoside metabolically stable to the action
of sialidases [27]. Apart from Neu5Ac-2-S-(a2,3)-Galb1Me 1,
all other substrate-like compounds tested that is, 6, 7, and 8,
did not inhibit the sialidase. This outcome combined with
the fact that 6–8 are a2,6-sialylmimetics further supports
the notion that the cytosolic sialidase has an a2,3-linkage
preference [5–7].
Investigation of the recombinant sialidase-promoted hydro-
lysis reaction revealed that it was a retaining sialidase and that
hydrolysis of the synthetic substrate proceeds with retention of
anomeric conﬁguration. The general ﬁndings of this study and
others [24–30] suggest that irrespective of the source of the en-
zyme all sialidases appear to be retaining enzymes.
The present study provides some further useful characterisa-
tion of the recombinant enzyme activity.
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